Since 2016, the Association of Public Health Laboratories, Inc. (APHL) has collaborated with the U.S. Centers for Disease Control and Prevention’s (CDC) National Center for Immunization and Respiratory Diseases (NCIRD) to build laboratory capacity in order to detect and respond to respiratory and vaccine preventable pathogens of global health security (GHS) concern. CDC also executed related internal initiatives and partnered with other organizations such as Institute Pasteur to build global laboratory capacity. In 2020, APHL contracted SGNL Solutions to help measure the effectiveness of these laboratory-focused GHS activities provided to NCIRD through GHS funds to support activities carried out between 2016 and 2019 calendar years.
Through this project, SGNL will:
Explain how and if NCIRD GHS activities contributed to both country and CDC NCIRD programmatic advancements
Document the financial investment related to the activities in relation to measurable outcomes
Document key lessons learned, challenges, and successes to help inform future programming